German Prefilled Syringe Manufacturer to Double Production Capability

Structural work for the facility enlargement, which will more than double its current capacity, had been completed with the site being on schedule to become fully operational in 2017.

Among Vetter's many products is the patented dual-chamber syringe. A freeze-dried (lyophilized) drug resides in one chamber; liquid in the other. Pushing the plunger mixes the two, reconstituting the drug. The technology prolongs shelf-life, facilitates accurate dosing, and enables patients to self-administer.

“We are continuously monitoring and reacting to a changing marketplace and are pleased that we are in the position to be able to make these strategic investments to further develop our sites and meet these challenges. Individually and collectively, they will help us keep pace with the market and allow us to continue to build a successful future for Vetter and our customers,” said Peter Soelkner managing director of Vetter.

Related Links:
Vetter